10-Q: Arteris, Inc. Reports Q1 2025 Results: Revenue Up 28% Year-Over-Year, Driven by Licensing Growth

Arteris, Inc. announced a 28% increase in revenue for the first quarter of 2025, primarily driven by growth in licensing, support, and maintenance revenue.

Summary

• Arteris, Inc. reported its financial results for the first quarter ended March 31, 2025.
• The company's total revenue increased by 28% year-over-year to $16.5 million, compared to $12.9 million in Q1 2024.
• Licensing, support, and maintenance revenue rose to $15.3 million from $11.7 million in the same period last year.
• Variable royalties increased to $1.2 million from $0.8 million year over year.
• The company experienced a net loss of $8.1 million, or $0.20 per share, compared to a net loss of $9.4 million, or $0.25 per share, in Q1 2024.
• Operating expenses totaled $22.7 million, up from $20.6 million in the prior year.
• Research and development expenses increased to $11.9 million, while sales and marketing expenses rose to $6.5 million.
• General and administrative expenses remained relatively flat at $4.3 million.
• As of March 31, 2025, Arteris had $42.3 million in cash and cash equivalents and short-term investments.
• Annual Contract Value (ACV) was $62.1 million, and ACV plus royalties was $66.8 million.
• The company had 17 Confirmed Design Starts during the quarter.
• Remaining Performance Obligations (RPO) stood at $88.9 million.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While revenue growth is positive, the continued net loss and increasing operating expenses are concerning. The company's strategic focus and market opportunities provide some optimism.

Positives

• Revenue increased by 28% year-over-year, indicating strong growth.
• Licensing, support, and maintenance revenue showed significant growth.
• Net loss improved compared to the same quarter last year.
• Annual Contract Value (ACV) increased, reflecting customer commitment.
• Confirmed Design Starts indicate future royalty revenue potential.
• Remaining Performance Obligations (RPO) increased, providing future revenue visibility.

Negatives

• The company reported a net loss of $8.1 million for the quarter.
• Operating expenses increased, driven by higher research and development and sales and marketing costs.
• The company's accumulated deficit is $145.0 million as of March 31, 2025.

Risks

• The semiconductor industry is cyclical and subject to rapid technological change.
• The company faces significant competition from larger companies.
• The company depends on market acceptance of third-party semiconductor IP.
• The company's dependence on international customers and operations also subjects it to a range of other additional regulatory, operational, financial, and political risks that could adversely impact its financial results.
• Changes in legislation and regulation in the U.S. and other countries, including new trade policies and the imposition of tariffs, may adversely impact the company's business, results of operations and financial condition.
• The company faces risks associated with doing business in China.
• The company may be unable to protect its proprietary technology and inventions through patents and other intellectual property rights.
• The company is subject to data protection, privacy and security laws, regulations, standards and other requirements across different markets where it conducts its business.

Future Outlook

The company believes its cash and investments will be sufficient to meet its expected working capital needs for at least the next 12 months. The company expects R&D expenses to increase in absolute terms and as a percentage of revenue in the short term and to continue to increase in absolute terms in the medium to long term but decrease as a percentage of revenue as certain new products are launched. The company expects S&M expenses to increase in absolute terms but decrease as a percentage of revenue due to productivity improvements of our sales processes. The company expects G&A expenses to increase as our business grows. In addition, we expect G&A expenses as a percentage of revenue to vary from period to period but generally decrease over the long term.

Management Comments

• Growth for our solutions is being driven by growing SoC sophistication and associated complexity, now extending into disaggregation of SoCs into systems which implement the communication protocol aspects and partner with industry leading providers like Synopsys, Cadence, Alphawave and others to connect to their die-to-die interfaces.
• We believe this increase in SoC complexity has created a significant opportunity for sophisticated System IP products that incorporate NoC interconnect IP, SoC Integration Automation software (formerly IP deployment software) and NoC interface IP (consisting of peripheral data transport IP and control plane networks connected to NoC interconnect IPs).
• Moreover, our technology can also provide more cost-effective solutions and reduce the risks of building and maintaining in-house NoC teams, which we believe has positively contributed to our market segment share growth.

Industry Context

The company operates in the semiconductor IP market, which is driven by the increasing complexity of SoCs and the need for efficient on-chip communication. The company's solutions compete with both in-house development efforts and other third-party IP providers. The company's growth is tied to the adoption of its technology in key markets such as automotive, enterprise computing, communications, consumer electronics, and industrial.

Comparison to Industry Standards

• It is difficult to compare Arteris' results directly to industry standards due to the company's unique focus on on-chip interconnect technology.
• However, comparable companies in the broader semiconductor IP market include Arm Holdings and Synopsys, which offer a wider range of IP solutions.
• Arm Holdings, a major competitor, reported revenue of $928 million for the quarter ended December 31, 2023, demonstrating the scale of larger players in the IP market.
• Synopsys, another competitor, reported revenue of $1.65 billion for the quarter ended January 31, 2024, highlighting the diverse offerings and revenue streams of established companies.
• Arteris' ACV of $62.1 million and RPO of $88.9 million suggest a growing customer base and future revenue potential, but the company's net losses indicate a need to improve profitability.
• Compared to industry giants, Arteris is still in a growth phase, focusing on expanding its market share and achieving sustainable profitability.

Legal Proceedings

• In December 2022, the Company received notice of a complaint filed against the Company and another defendant in the semiconductor industry, by Network System Technologies, LLC (NST) in the United States District Court for the Western District of Texas.
• On September 4, 2024, the court in the Western District of Texas dismissed all claims against the Company without prejudice.
• The Company has not received any new claims involving the Company nor any new customer indemnity claims in connection with the NST litigation.

Related Party Transactions

• On November 15, 2024, the Company entered into a design services licensing collaboration agreement with Transchip.
• In November 2020, the Company entered into a lease agreement with Isabelle Geday, a former member of the board of directors, who resigned from her position as director of the Company effective March 27, 2025.
• In addition, the Company signed a consulting agreement with Ms. Geday on December 1 , 2021, which was subsequently assigned to Magillem Design Services S.A., effective January 10, 2022.

Stakeholder Impact

• Shareholders: The revenue growth is positive, but the net loss may be concerning.
• Employees: The company is investing in research and development and sales and marketing, which could create opportunities for employees.
• Customers: The company is focused on providing high-quality support and expanding its product offerings.
• Suppliers: The company's financial stability is important for maintaining relationships with suppliers.

Next Steps

• The company will continue to invest in research and development to expand its product offerings.
• The company will focus on expanding its sales and marketing efforts to increase its customer base.
• The company will continue to monitor and manage its international operations and associated risks.
• The company will continue to monitor future events and developments that would impact its assessment and if future facts and circumstances indicate that decline in fair value of the investment is other than temporary, a significant impairment may be recorded.

Key Dates

Keywords

revenue, licensing, semiconductor IP, ACV, royalties, net loss, design starts, RPO, Arteris, financial results